INmune Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.

CEO

Raymond J. Tesi

CEORaymond J. Tesi

Employees

Employees22

Headquarters

Boca Raton, Florida

HeadquartersBoca Raton, Florida

Founded

2015

Founded2015

Employees

Employees22

INMB Key Statistics

Market cap

182.89M

Market cap182.89M

Price-Earnings ratio

-4.03

Price-Earnings ratio-4.03

Dividend yield

—

Dividend yield—

Average volume

249.89K

Average volume249.89K

High today

$7.92

High today$7.92

Low today

$7.29

Low today$7.29

Open price

$7.34

Open price$7.34

Volume

296.92K

Volume296.92K

52 Week high

$11.36

52 Week high$11.36

52 Week low

$4.32

52 Week low$4.32

People also own

Based on the portfolios of people who own INMB. This list is generated using Robinhood data, and it’s not a recommendation.